Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
pacritinib | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] |
0.66 | phase 3 | unknown |
pacritinib | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] |
0.66 | phase 3 | inhibitor |
pacritinib | janus kinase 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] |
0.7 | phase 3 | inhibitor |
pacritinib | janus kinase 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary Myelofibrosis[MeSHID:D055728] |
0.7 | phase 3 | unknown |
click here to return to the previous page |